Where does Cellerant Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cellerant Therapeutics, Inc. ranks #22,351 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cellerant Therapeutics, Inc. hold?

Cellerant Therapeutics, Inc. holds 12 US utility patents granted between 2015 and 2021, spanning 9 technology areas.

What is Cellerant Therapeutics, Inc.'s Innovation Score?

Cellerant Therapeutics, Inc. has an Innovation Score of 32.8 out of 100 (top 58% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cellerant Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Cellerant Therapeutics, Inc.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Cellerant Therapeutics, Inc.'s patents?

Cellerant Therapeutics, Inc.'s patents average 22.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cellerant Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cellerant Therapeutics, Inc.

Q: What technology areas does Cellerant Therapeutics, Inc. focus on?

Cellerant Therapeutics, Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 12 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cellerant ranks #22,351 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#22,351
of 50,000 US assignees by volume: Top 58%
by Innovation Score (32.8/100): 22.2
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22351 · US Corporation #22,351 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,351/50,000
PHOTO-FINISH Caret Holdings
CPC-NARROW A61P · 9 areas
INNOV-THIN 32.8/100
CLAIMS-DENSE 22.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Caret Holdings, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cellerant Therapeutics · this assignee

33
3D Lighting Innovati… · lowest

7

What this shows Cellerant's Innovation Score is 32.8/100 (top 58% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Cellerant's grants concentrate

Cellerant Therapeutics, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2015. By volume, Cellerant sits between Caret Holdings, Inc. and Celtaxsys, Inc..

Caret Holdings

12
Carlisle Intangib…

12
Carrier Commercia…

12
Cascade Designs

12
Cellestis

12
Cellium

12
Celonis SE

12
Celtaxsys

12
Cellerant Therape… ◀

12

What this shows Cellerant holds 12 patents at rank #22,391, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cellerant

By rank, the assignees closest to #22,391 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Cellerant's primary technology class.

Cellerant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 Top 58% higher than 42% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cellerant Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2016	2	16.7%
2017	2	16.7%
2018	1	8.3%
2019	3	25.0%
2020	1	8.3%
2021	2	16.7%

Which technologies does Cellerant Therapeutics, Inc. patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 12

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 12

C07K - PEPTIDES 11

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7

C07D - HETEROCYCLIC COMPOUNDS 4

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#22,351

of 50,000 tracked assignees

Innovation Score

32.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.